RS Group PLC shares rose about 9% after the company announced a 2% increase in its full-year dividend to 22.9p per share and launched a £100 million share buyback program. Despite a 1% drop in revenue to £2.88 billion and a 3% decline in adjusted operating profit to £265 million for the year ending March 2026, strong cash flow and reduced net debt to £329 million helped offset weaker profit performance. The company reported improved gross margins and exceeded its cash conversion target, signaling financial resilience amid challenging industrial markets. RS Group also reaffirmed its medium-term growth targets, aiming to grow revenue at twice the market rate and maintain strong operating margins and returns on capital.
Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...
AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...
PNC Financial Services Group reported Q2 2026 adjusted EPS of $4.85 and record revenue of $6.88 billion, surpassing analyst expectations. The growth was driven by a 15.5% rise in net interest income and a 31.4% increase in fee income, reflecting stro...
Greenlight, a leading cannabis operator, expanded its Ohio presence by opening four new dispensaries and adding in-state manufacturing, reaching the state's maximum allowed eight dispensaries. This move strengthens Greenlight's position in Ohio's lim...
Halper Sadeh LLC is investigating whether shareholders of Element Solutions Inc (ESI), Crinetics Pharmaceuticals (CRNX), and Solstice Advanced Materials (SOLS) are receiving fair treatment in their respective sale and merger transactions. The firm hi...
